TLR9 and B-cell non-Hodgkin lymphoma: Meanwhile, we analyzed 760 samples of B-cell malignant tumors, and the survival rates of patients with high TLR9 expression were all better than that of patients with low expression, suggesting a close relationship between high TLR9 expression and a good prognosis in patients with B-cell lymphoma (Fig. 8C).